MedPath

Improving In-hospital Stroke Service Utilisation in China

Not Applicable
Completed
Conditions
Thrombolytic Therapy
Quality Improvement
Acute Stroke
Door to Treatment Time
Interventions
Behavioral: Behaviour Change Wheel model guided intervention
Registration Number
NCT03317639
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brief Summary

A cluster randomised controlled trial will be conducted, using hospital as randomisation unit. Hospitals in Zhejiang Province, China, will be randomised into two arms (1:1): an intervention arm and a control arm. Hospitals in the intervention arm will receive a multi-components intervention based on the Behaviour Change Wheel model, whereas hospitals in the control arm will receive no intervention and maintain existing care. The randomisation will be conducted after one-year baseline data collection. The following baseline data will be used for randomisation match: hospital classification, beds in stroke centre, thrombolysis patient number, and percentage of patients receiving thrombolysis within 60 minutes of stroke onset. Hospitals with no stroke centre or with \<20 cases received thrombolysis per year will be excluded from the study. The primary outcome will be difference between intervention arm and control arm in the percentage of patients receiving thrombolysis within 60 minutes of stroke onset on the follow-up stage (post-intervention).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1634
Inclusion Criteria
  • AIS patients receiving IVT within 4.5 hours
Exclusion Criteria
  • Patients who are not willing to attend this trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
an intervention armBehaviour Change Wheel model guided interventionHospitals in the intervention arm will receive a multi-components intervention based on the Behaviour Change Wheel model
Primary Outcome Measures
NameTimeMethod
Difference in the percentage of patients who Door-to-Needle Time≤60minUp to 24 hours

Difference between intervention arm and control arm in the percentage of patients receiving thrombolysis within 60 minutes of stroke onset on the follow-up stage

Secondary Outcome Measures
NameTimeMethod
Onset-to-needle timeUp to 24 hours

The time between the symptom onset and the initiation of IVT

modified Rankin Scale score at dischargeUp to 3 month

modified Rankin Scale score at discharge, on which scores range from 0 (no neurologic deficit) to 6 (death)

Door-to-needle timeUp to 24 hours

The time between hospital arrival and the initiation of IVT

DeathUp to 3 month

Death at discharge

Symptomatic intracranial hemorrhageAt 24 hours

Intracranial hemorrhage at 24 hours associated with an increase of ≥4 points of NIHSS score from baseline, according to European Cooperative Acute Stroke Study (ECASS) II trial

Favorable neurological outcomesAt 90 days

Score of 0 to 1 on the modified Rankin Scale, on which scores range from 0 (no neurologic deficit) to 6 (death)

Trial Locations

Locations (1)

The second affiliated hospital of Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath